Phase 2 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to follow the trial's treatment schedule, attend all visits, complete required tests, and sign a consent form agreeing to take part.
- People who are 18 years of age or older at the time of signing the consent form. Any gender is eligible.
- People whose general physical health and ability to carry out daily activities falls within a certain range, rated 0 or 1 on a standard scale used by doctors to measure cancer patients' wellbeing (confirm with trial site).
- People whose doctors expect them to live for at least 12 weeks.
- People who have at least one tumour or lesion that can be measured using standard imaging methods.
- Women who are able to become pregnant must be willing to use highly effective contraception from the time of signing the consent form until at least 6 months after the last dose of the trial drug, and must have a negative pregnancy test within 7 days before the first dose.
Who may not be able to join:
- People who are currently taking part in another clinical trial, or who have received another experimental treatment within the 4 weeks before the first dose of this trial's drug.
- People who have used immune-modifying medications within the 2 weeks before the first dose of the trial drug.
- People who have an active infection currently requiring ongoing treatment throughout the body, or who have active tuberculosis, or who have received tuberculosis treatment within the past 6 months.
- People who have fluid build-up in the chest, around the heart, or in the abdomen that cannot be controlled medically and requires repeated draining or ongoing medical procedures.
- People who have a history of immune system deficiency, including those who test positive for HIV antibodies.
- People with currently active hepatitis B or hepatitis C infection.
- People who are currently pregnant or breastfeeding.
- People with a history of mental illness that affects their ability to understand or consent to the trial, or a history of drug abuse, alcoholism, or drug addiction.
- People whom the trial doctor considers to have other conditions that may affect their ability to follow the trial requirements or that make participation unsuitable.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: lingying wu, Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phone: 025-83378099
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective Response Rate (ORR); Occurrence of adverse event (AE) and serious adverse event (SAE); Progression-free Survival(PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.